A molecule that could burn more energy, target hepatic fat directly, and still suppress appetite would, in principle, close several of those gaps at once
Carbohydrates: Fill remaining calories after protein and fat targets are met
Originally derived from gastric proteins, it helps strengthen the GI barrier and support digestive balance
GHK-Cu research documents upregulation of FOXO3-adjacent gene networks, suggesting the peptide may interface with core longevity signaling at the transcriptional level
Backed by emerging research and clinical demand, weight loss peptides are increasingly being integrated into medically supervised programs
GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like semaglutide and tirzepatide produce fat loss primarily through appetite suppression and reduced caloric intake rather than direct fat cell targeting